Parvovirus B19 in HIV+ adult patients with different CD4+ lymphocyte counts.
CONCLUSIONS: The results indicate that B19V is not a high-risk factor for anemia in adult HIV+ patients under HAART treatment. Further studies will contribute to elucidate the mechanisms and significance of B19V DNA prevalence/persistence in adults, independently of the CD4+ cell status.
PMID: 29095139 [PubMed - as supplied by publisher]
Source: Journal of Medical Microbiology - Category: Microbiology Authors: Pedranti MS, Rodriguez-Lombardi G, Bracciaforte R, Romano N, Lujan P, Ricchi B, Mautino J, Adamo MP Tags: J Med Microbiol Source Type: research
More News: Anemia | Erythema Infectiosum | Highly Active Antiretroviral Therapy | Microbiology | Parvovirus | Study